alanylproline has been researched along with prolylvaline in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marshall, GR; Waller, CL | 1 |
| Brandsch, M; Gebauer, S; Hartrodt, B; Knütter, I; Neubert, K; Thondorf, I | 1 |
| Feng, F; Huo, J; Jin, H; Wang, W; Wang, Y; Wang, Z; Zhang, L; Zhang, S; Zhou, L | 1 |
| Aldini, G; De Luca, L; Marconi, C; Pedretti, A; Regazzoni, L; Vistoli, G | 1 |
| He, Z; Li, T; Lu, D; Qi, W; Su, R; Wu, S | 1 |
5 other study(ies) available for alanylproline and prolylvaline
| Article | Year |
|---|---|
Three-dimensional quantitative structure-activity relationship of angiotesin-converting enzyme and thermolysin inhibitors. II. A comparison of CoMFA models incorporating molecular orbital fields and desolvation free energies based on active-analog and com
Topics: Angiotensin-Converting Enzyme Inhibitors; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Thermolysin | 1993 |
Three-dimensional quantitative structure-activity relationship analyses of peptide substrates of the mammalian H+/peptide cotransporter PEPT1.
Topics: Carrier Proteins; Dipeptides; Drug Design; Ligands; Models, Molecular; Molecular Conformation; Peptide Transporter 1; Protein Binding; Quantitative Structure-Activity Relationship; Symporters | 2003 |
Angiotensin-I-converting enzyme inhibitory peptides: Chemical feature based pharmacophore generation.
Topics: Algorithms; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Databases, Factual; Humans; Hydrogen Bonding; Hypertension; Male; Models, Chemical; Models, Molecular; Peptides; Peptidyl-Dipeptidase A; Quantitative Structure-Activity Relationship; Software; Solutions; Testis | 2011 |
Fragmental modeling of hPepT2 and analysis of its binding features by docking studies and pharmacophore mapping.
Topics: Binding Sites; Computer Simulation; Drug Design; Humans; Ligands; Models, Molecular; Peptides; Protein Binding; Structural Homology, Protein; Symporters | 2011 |
CoMFA and CoMSIA analysis of ACE-inhibitory, antimicrobial and bitter-tasting peptides.
Topics: Algorithms; Angiotensin-Converting Enzyme Inhibitors; Anti-Infective Agents; Models, Molecular; Peptides; Quantitative Structure-Activity Relationship; Regression Analysis; Taste | 2014 |